Benabente, Helfseth P.
HRN: 28-96-96 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
CEFTRIAXONE 1G (VIAL)
05/10/2026
05/16/2026
IV
2G
OD
HEPATIC PATHOLOGY
Checking Initial Appropriateness
05/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/11/2026
05/18/2026
IV
4.5g
Q 6 Hours
Hepatic Pathology
Checking Initial Appropriateness
05/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/13/2026
05/20/2026
IV
500mg
Q 8 Hours
Hepatobiliary Pathology
Checking Initial Appropriateness